156 related articles for article (PubMed ID: 30056066)
21. New Evidence and Perspectives on the Management of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
Yin J; Bo WT; Sun J; Xiang X; Lang JY; Zhong JH; Li LQ
J Clin Transl Hepatol; 2017 Jun; 5(2):169-176. PubMed ID: 28660155
[TBL] [Abstract][Full Text] [Related]
22. Characteristics and outcomes of hepatocellular carcinoma patients with macrovascular invasion following surgical resection: a meta-analysis of 40 studies and 8,218 patients.
Huang DQ; Tran A; Tan EX; Nerurkar SN; Teh R; Teng MLP; Yeo EJ; Zou B; Wong C; Esquivel CO; Bonham CA; Nguyen MH
Hepatobiliary Surg Nutr; 2022 Dec; 11(6):848-860. PubMed ID: 36523924
[TBL] [Abstract][Full Text] [Related]
23. Survival benefit of perioperative locoregional adjuvant treatment for hepatocellular carcinoma with portal vein tumor thrombosis: A systematic review and Bayesian network meta-analysis.
Sun H; Ma B; Sun N; Bai H; Li X; Zhang C
Crit Rev Oncol Hematol; 2023 Sep; 189():104083. PubMed ID: 37536447
[TBL] [Abstract][Full Text] [Related]
24. Survival outcomes after caudate lobectomy for hepatocellular carcinoma: systematic review and meta-analysis.
Al-Ameri AAM; Zheng S
ANZ J Surg; 2024 Mar; 94(3):335-341. PubMed ID: 38193603
[TBL] [Abstract][Full Text] [Related]
25. Liver resection versus transarterial chemoembolization for the initial treatment of Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma.
Yang B; Zheng B; Yang M; Zeng Z; Yang F; Pu J; Li C; Liao Z
Hepatol Int; 2018 Sep; 12(5):417-428. PubMed ID: 30073454
[TBL] [Abstract][Full Text] [Related]
26. Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
Liu YS; Lin CY; Chuang MT; Lin CY; Tsai YS; Wang CK; Ou MC
BMC Gastroenterol; 2018 Aug; 18(1):124. PubMed ID: 30075752
[TBL] [Abstract][Full Text] [Related]
27. Percutaneous thermal ablation combined with TACE versus TACE monotherapy in the treatment for liver cancer with hepatic vein tumor thrombus: A retrospective study.
Wang Y; Ma L; Yuan Z; Zheng J; Li W
PLoS One; 2018; 13(7):e0201525. PubMed ID: 30063737
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant transarterial chemoembolization for patients with hepatocellular carcinoma involving microvascular invasion.
Qi YP; Zhong JH; Liang ZY; Zhang J; Chen B; Chen CZ; Li LQ; Xiang BD
Am J Surg; 2019 Apr; 217(4):739-744. PubMed ID: 30103903
[TBL] [Abstract][Full Text] [Related]
29. Comparison of local tumor control in patients with HCC treated with SBRT or TACE: a propensity score analysis.
Bettinger D; Gkika E; Schultheiss M; Glaser N; Lange S; Maruschke L; Buettner N; Kirste S; Nestle U; Grosu AL; Thimme R; Brunner TB
BMC Cancer; 2018 Aug; 18(1):807. PubMed ID: 30092781
[TBL] [Abstract][Full Text] [Related]
30. Emerging therapies in advanced hepatocellular carcinoma.
Medavaram S; Zhang Y
Exp Hematol Oncol; 2018; 7():17. PubMed ID: 30087805
[TBL] [Abstract][Full Text] [Related]
31. A new laboratory-based algorithm to predict microvascular invasion and survival in patients with hepatocellular carcinoma.
Zhu Y; Xu D; Zhang Z; Dong J; Zhou Y; Zhang WW; Hong L; Zhu WW
Int J Surg; 2018 Sep; 57():45-53. PubMed ID: 30075291
[TBL] [Abstract][Full Text] [Related]
32. Multicentric Assessment of the Hong Kong Liver Cancer Staging System in Chinese Patients Following Transarterial Chemoembolization.
Zhong BY; Ni CF; Yin GW; Chen L; Zhu HD; Guo JH; He SC; Deng G; Zhang Q; Li PC; Yu H; Teng GJ
Cardiovasc Intervent Radiol; 2018 Dec; 41(12):1867-1876. PubMed ID: 30073478
[TBL] [Abstract][Full Text] [Related]
33. Resection might be a meaningful choice for hepatocellular carcinoma with portal vein thrombosis: A systematic review and meta-analysis.
Zhang ZY; Dong KS; Zhang EL; Zhang LW; Chen XP; Dong HH
Medicine (Baltimore); 2019 Dec; 98(50):e18362. PubMed ID: 31852141
[TBL] [Abstract][Full Text] [Related]
34. Neoadjuvant Three-Dimensional Conformal Radiotherapy for Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Randomized, Open-Label, Multicenter Controlled Study.
Wei X; Jiang Y; Zhang X; Feng S; Zhou B; Ye X; Xing H; Xu Y; Shi J; Guo W; Zhou D; Zhang H; Sun H; Huang C; Lu C; Zheng Y; Meng Y; Huang B; Cong W; Lau WY; Cheng S
J Clin Oncol; 2019 Aug; 37(24):2141-2151. PubMed ID: 31283409
[TBL] [Abstract][Full Text] [Related]
35. Systemic Therapy and Sequencing Options in Advanced Hepatocellular Carcinoma: A Systematic Review and Network Meta-analysis.
Sonbol MB; Riaz IB; Naqvi SAA; Almquist DR; Mina S; Almasri J; Shah S; Almader-Douglas D; Uson Junior PLS; Mahipal A; Ma WW; Jin Z; Mody K; Starr J; Borad MJ; Ahn DH; Murad MH; Bekaii-Saab T
JAMA Oncol; 2020 Dec; 6(12):e204930. PubMed ID: 33090186
[TBL] [Abstract][Full Text] [Related]
36. Comparison of Radioembolization and Sorafenib for the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Systematic Review and Meta-Analysis of Safety and Efficacy.
Kim PH; Choi SH; Kim JH; Park SH
Korean J Radiol; 2019 Mar; 20(3):385-398. PubMed ID: 30799569
[TBL] [Abstract][Full Text] [Related]
37. Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial.
Kudo M; Ueshima K; Ikeda M; Torimura T; Tanabe N; Aikata H; Izumi N; Yamasaki T; Nojiri S; Hino K; Tsumura H; Kuzuya T; Isoda N; Yasui K; Aino H; Ido A; Kawabe N; Nakao K; Wada Y; Yokosuka O; Yoshimura K; Okusaka T; Furuse J; Kokudo N; Okita K; Johnson PJ; Arai Y;
Gut; 2020 Aug; 69(8):1492-1501. PubMed ID: 31801872
[TBL] [Abstract][Full Text] [Related]
38. Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial.
Qin S; Ren Z; Meng Z; Chen Z; Chai X; Xiong J; Bai Y; Yang L; Zhu H; Fang W; Lin X; Chen X; Li E; Wang L; Chen C; Zou J
Lancet Oncol; 2020 Apr; 21(4):571-580. PubMed ID: 32112738
[TBL] [Abstract][Full Text] [Related]
39. Jiedu Granule Combined with Transcatheter Arterial Chemoembolization and Gamma Knife Radiosurgery in Treating Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
Wang J; Luo J; Yin X; Huang W; Cao H; Wang G; Wang J; Zhou J
Biomed Res Int; 2019; 2019():4696843. PubMed ID: 31341898
[TBL] [Abstract][Full Text] [Related]
40. Preoperative strategies to improve resectability for hepatocellular carcinoma: a systematic review and meta-analysis.
Tustumi F; Ernani L; Coelho FF; Bernardo WM; Junior SS; Kruger JAP; Fonseca GM; Jeismann VB; Cecconello I; Herman P
HPB (Oxford); 2018 Dec; 20(12):1109-1118. PubMed ID: 30057123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
